Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-04-15

Clinical Trial Update: The Role of 1.5-anhydro-D-glucitol as Clinical Biomarkers of Hypoglycemia in Patients With Diabetes

View source ↗

Summary

This clinical trial update evaluates whether 1.5-anhydro-D-glucitol can serve as a biomarker for hypoglycemia in people with type 2 diabetes mellitus. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Seoul National University Hospital | Conditions: Type 2 Diabetes Mellitus With Hypoglycemia | Status: COMPLETED